Th
e
Biden administration on Tuesday is expected to take the first step in a new effort to cut prescription drug costs for millions of Americans, a move that the president is touting as one of his signature policy achievements. Th
e
Centers for Medicare and Medicaid Services will release a list of 10 drugs whose prices will be subject to negotiation for Medicare patients, a plan green-lighted in last year’s Inflation Reduction Act. Bu
t
the effort will face hurdles — including lawsuits from drugmakers — before older adults see cost savings on their medications. Here’s how things could play out: Wh
en
Disclaimer: This article may require a subscription.